Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Youngran Cho"'
Autor:
Seonghyun Lee, Jisun Lee, Sun-Hee Cho, Gahyun Roh, Hyo-Jung Park, You-Jeung Lee, Ha-Eun Jeon, Yu-Sun Lee, Seo-Hyeon Bae, Sue Bean Youn, Youngran Cho, Ayoung Oh, Dahyeon Ha, Soo-Yeon Lee, Eun-Jin Choi, Seongje Cho, Sowon Lee, Do-Hyung Kim, Min-Ho Kang, Mee-Sup Yoon, Byung-Kwan Lim, Jae-Hwan Nam
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract The implications of administration of mRNA vaccines to individuals with chronic inflammatory diseases, including myocarditis, rheumatoid arthritis (RA), and inflammatory bowel disease (IBD), are unclear. We investigated mRNA vaccine effects
Externí odkaz:
https://doaj.org/article/9c99544e79be48e9a215db542194e81e
Autor:
Sagar B Kudchodkar, Paolo Fagone, Omkar U Kawalekar, Moonsup Jeong, Christine C Roberts, Hyojin Lee, Youngran Cho, Areum Gil, Yeeun Oh, Bohyun Jeon, Gee Ho Park, Young K Park, Ferdinando Nicoletti, Joel N Maslow, Kar Muthumani
Publikováno v:
Translational Medicine Communications, Vol 7, Iss 1, Pp 1-15 (2022)
Abstract In the present study, the effect(s) of the immunomodulatory drug GLS-1027 on various cell types involved in inflammation were investigated. GLS-1027 reduced LPS-stimulated secretion of pro-inflammatory cytokines by macrophage or monocytic ce
Externí odkaz:
https://doaj.org/article/405ed5a8ca7941f389f90989ca81b381
Autor:
Moonsup Jeong, Sagar B. Kudchodkar, Areum Gil, Bohyun Jeon, Gee Ho Park, Youngran Cho, Hyojin Lee, Mi Sun Cheong, Wonil Kim, Yun-Ho Hwang, Jung-Ah Lee, Heeji Lim, Mi Young Kim, Emran O. Lallow, Tej Brahmbhatt, Stephen A. Kania, Nandita C. Jhumur, Jerry W. Shan, Jeffrey D. Zahn, David I. Shreiber, Jonathan P. Singer, Hao Lin, Erin K. Spiegel, Laurent Pessaint, Maciel Porto, Alex Van Ry, Danielle Nase, Swagata Kar, Hanne Andersen, Ian Tietjen, Joel Cassel, Joseph M. Salvino, Luis J. Montaner, Young K. Park, Kar Muthumani, Christine C. Roberts, Joel N. Maslow
Publikováno v:
Frontiers in Virology, Vol 2 (2022)
SARS-CoV-2 is the third pathogenic coronavirus to emerge since 2000. Experience from prior outbreaks of SARS-CoV and MERS-CoV has demonstrated the importance of both humoral and cellular immunity to clinical outcome, precepts that have been recapitul
Externí odkaz:
https://doaj.org/article/c73deb36ca654fa2815416d4cd1e4dd1
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 10, Pp 2249-2257 (2019)
Infection caused by the severe fever and thrombocytopenia syndrome virus (SFTSV) causes a hemorrhagic illness with a mortality between 20% and 40%. Initially recognized in 2009 in China, cases have additionally been documented in Japan and Korea alth
Externí odkaz:
https://doaj.org/article/9107552a8c834eac8a7e2e8970c571dd
Autor:
Jeong-Eun Kwak, Young-Il Kim, Su-Jin Park, Min-Ah Yu, Hyeok-Il Kwon, Sukyeong Eo, Tae-Shin Kim, Joon Seok, Won-Suk Choi, Ju Hwan Jeong, Hyojin Lee, Youngran Cho, Jin Ah Kwon, Moonsup Jeong, Joel N. Maslow, Yong-Eun Kim, Haili Jeon, Kee K. Kim, Eui-Cheol Shin, Min-Suk Song, Jae U. Jung, Young Ki Choi, Su-Hyung Park
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne virus with no specific treatment or vaccine available. Here, the authors develop a DNA vaccine for SFTSV that is protective against lethal challenge in ferrets and sh
Externí odkaz:
https://doaj.org/article/070e15f3b66f4dec8015fa9c64ead744
Autor:
Young Ki Choi, Ju Hwan Jeong, Tae-Shin Kim, Yong-Eun Kim, Young-Il Kim, Hyeok-il Kwon, Jeong-Eun Kwak, Eui-Cheol Shin, Min-Suk Song, Joel N. Maslow, Kee K. Kim, Su-Hyung Park, Min-Ah Yu, Youngran Cho, Sukyeong Eo, Jin Ah Kwon, Jae U. Jung, Joon Seok, Su-Jin Park, Moonsup Jeong, Haili Jeon, Won-Suk Choi, Hyo Jin Lee
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
Nature Communications
Nature Communications
Although the incidence of severe fever with thrombocytopenia syndrome virus (SFTSV) infection has increased from its discovery with a mortality rate of 10–20%, no effective vaccines are currently available. Here we describe the development of a SFT
Autor:
Susan E. Spruill, Jackie Jin-Ah Kwon, Youngran Cho, Joel N. Maslow, Moonsup Jeong, Susan K. Mikota
Publikováno v:
Human Vaccines & Immunotherapeutics
Infection caused by the severe fever and thrombocytopenia syndrome virus (SFTSV) causes a hemorrhagic illness with a mortality between 20% and 40%. Initially recognized in 2009 in China, cases have additionally been documented in Japan and Korea alth
Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity
Autor:
Youngran Cho, Jong Hoon Kim, Jeong-Eun Kwak, Su-Hyung Park, A. Reum Kim, Junsik Park, Eui-Cheol Shin, Hyo Jin Lee, Moonsup Jeong
Publikováno v:
Immune Network
Herpes zoster (HZ), or shingles, is caused by the reactivation of latent varicella-zoster virus (VZV) from the sensory ganglia when VZV-specific T-cell immunity is decreased because of aging or immunosuppression. In the present study, we developed HZ
Autor:
Woo-Chan Son, Byung Mun Cho, David B. Weiner, Hyojin Lee, Youngran Cho, Moonsup Jeong, Amir S. Khan, Joel N. Maslow, Jooyeon Oh, Jian Yan, John E. Stone, Zachary Rothkopf, Xuefei Shen, Young Kyoung Park
Publikováno v:
Scientific Reports
Direct-acting antiviral treatment for hepatitis C virus (HCV) infection is costly and does not protect from re-infection. For human and chimpanzees, recovery from acute HCV infection correlates with host CD4+ and CD8+ T cell responses. DNA plasmids t
Publikováno v:
Clinical and Experimental Immunology. 174:38-44
Summary In the present study, we established a novel murine model of vitiligo by sequential prime/boost immunizations into the hind footpad and tail dermis with tyrosinase-related protein 2 (TRP2)-180 (SVYDFFVWL) peptide, lipopolysaccharides and cyto